Health Condition 1: O80- Encounter for full-term uncomplicated delivery Health Condition 2: N859- Noninflammatory disorder of uterus, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Women aged 18 to 50 years, undergoing laparotomy-based obstetric/ gynecological procedures 2. Women with CDC surgical wound classification class I/II 3. Women with good systemic/ mental health as per opinion of investigator 4. Subjects who have given written informed consent
Exclusion criteria
Exclusion criteria: 1. Women with BMI >30 Kg/m2 2. Women with hemoglobin levels 3. Women with a history of any laparotomy procedure or laparoscopic surgery 4. Women having urogenital tract infection within 2 weeks before the procedure 5. Women needing prophylactic mesh augmentation after laparotomy 6. Women undergoing elective/emergency laparoscopic abdominal surgeries 7. Women having active infection at or around the skin incision site 8. Women with history of allergy to nylon or similar products 9. Women already participating in another trial 10. Women unlikely to comply with the surgical procedure or complete the scheduled follow up visit, in the opinion of investigator 11. Other indication-based exclusion, in opinion of investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To compare the rate of wound infection with Trulon (Healthium) and Ethilon (J & J) polyamide suturesTimepoint: Day 3, Day 7-14, Week 6 and Week 12 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To evaluate tissue reaction, wound dehiscence, skin disruptions, suture sinus, seroma, and hematoma 2. To assess overall intraoperative handling between two sutures 3. To assess the amount of time subject takes to return back to normal day to day activities 4. To evaluate material problems and other adverse events 5. To evaluate postoperative discomfort, pain and overall subject satisfaction score 6. To evaluate and compare the resultant scar and cosmetic effects of two suturesTimepoint: Day 3, Day 7-14, Week 6 and Week 12 | — |
Countries
India
Contacts
Healthium Medtech Pvt.Ltd.